Gerard Henry, MD completed a urology residency with a 1 year basic science fellowship in men’s health at Duke University and is Board Certified by the American Board of Urology. In addition, he is the #1 US AMS IPP implanter over the last ten years, #1 published author on IPPs in the world over the last ten years, has won best clinical abstract at two national meetings, and has written 5 Journal of Urology CME articles on men’s health of which one was a cover article.

Dr. Henry is also the inventor of the Henry Mummy Wrap, Henry Finger Sweep, and New Length Measurement Technique. Currently, he is secretary of the Society of Urologic Prosthetic Surgeons and president-elect of the Louisiana Urology Society.

Atlanta, GA board-certified urologist Dr. Tariq S. Hakky is a world-renowned microsurgeon implementing the latest techniques and innovative treatments in men’s sexual health today. He is a diplomate of the American Board of Urology and Baylor College of Medicine fellowship-trained in male infertility and andrology. He is the owner and founder of Atlanta Cosmetic Urology and accepts patients of all genders desiring to improve urologic issues, sexual dysfunction, chronic pelvic pain, hormonal imbalances, weight-related issues, and more. Dr. Hakky has appeared as a guest on television shows (such as The Doctors), podcasts, and videos specifically about the latest topics in urology. He is a very respected urologist and microsurgeon among his peers nationally and internationally as a lecturer, presenter, author, and researcher in male reproductive medicine and urologic surgery.
Graduating at the top of his class, Dr. Hakky earned his medical degree from Florida State University College of Medicine in Tallahassee, FL with high honors. He was awarded a prestigious urology residency at the University of South Florida in Tampa, FL. He then went on to additionally train in the male infertility/andrology fellowship at Baylor College of Medicine in Houston, TX. This is where he honed valuable skills in improving men’s sexual health issues, like infertility, erectile dysfunction, penile implants, and hormone replacement therapy. As he trained at Baylor, one of the leading medical centers in the country, Dr. Hakky  provided care for many men with symptoms of low testosterone, which is another area of his specialties. In this fellowship, Dr. Hakky also studied to master the most advanced microsurgical vasectomy reversal techniques that less than 1% of urologists can perform. Today, he is known as one of the leaders in urology for microscopic male infertility procedures and vasectomy reversal microsurgery.
Dr. Hakky has received numerous awards for his work as a board-certified urologist in Atlanta, GA, including the 2018 Vitals Patient’s Choice Award as one of Georgia’s favorite physicians, the 2018 Compassionate Doctor Award, and the 2018 America’s Most Honored Professionals (Top 1%).

Dr. Ryan Owen is the newest member to the Clinical Advisory Board at Signati Medical. He is fellowship trained in male reproductive health and microsurgery. His medical journey began at Texas Tech University School of Medicine. After graduation, he began a Urology residency at The University of Tennessee and then completed an additional year of fellowship at the University of North Carolina. Currently living in Lubbock, Texas, his practice focuses on a wide range of urologic disease with a focus on male reproduction. He is an assistant professor at the Texas Tech University Urology residency program, where he has introduced residents and students to clinical and surgical aspects of male reproductive health.

Dr. Owen has contributed numerous publications toward the field of urology spanning from testosterone supplementation and erectile dysfunction to genetic testing for men seeking fertility. Given his focus toward the advancement of men’s health, Dr. Owen has joined the Signati Medical team with the ambition to help create a safe and efficient method to perform a non-invasive vasectomy procedure.

Dr. Owen is proud to serve his family and the West Texas community, in which he was raised. He is married and has 3 children. They spend time looking for adventure wherever they can find it.

Rahul Mehan, MD, is the founder of East Valley Urology (EVU) Center in Mesa, Arizona, and a board-certified urologist focusing on urologic oncology. He has extensive training in testicular, renal, prostate, and bladder cancers at EVU Center. He is a skilled surgeon and dedicated to providing his patients with the highest quality medical care.

Dr. Mehan retained his certification from the American Board of Urology and is affiliated with Banner Baywood Medical Center and Mercy Gilbert Medical Center in the Phoenix area. He is a published author with articles appearing in The Journal of UrologyⓇ and the Journal of Pediatric Urology. Dr. Mehan presents at regional and national meetings on a variety of urologic topics, including a presentation on testicular cancer using his original research at the American Urological Association’s 2011 Annual Meeting in Washington, D.C.

Dr. Mehan completed his undergraduate studies at Brigham Young University in Provo, Utah, and received his medical degree from Wright State University Boonshoft School of Medicine in Dayton, Ohio. Following his graduation, Dr. Mehan completed an internship in general surgery and a residency in urology at the Indiana University School of Medicine located on the campus of Purdue University.

In addition to providing quality care to his patients, Dr. Mehan enjoys playing basketball and tennis and has a passion for the outdoors. He loves spending time with his family.

Dr. Michel Labrecque MD, PhD (epidemiology) is an emeritus professor from the Department of Family and Emergency Medicine at Laval University, Quebec City, Canada. As of 2020, he has performed more than 35,000 vasectomies. He was the first physician to practice the No Scalpel Vasectomy (NSV) in Canada in 1992. He has taught NSV to over 60 clinicians nationally and internationally, has spoken at many international conferences, and has written extensively on the topic. He also worked with various non-governmental organizations (FHI360, EngenderHealth, No Scalpel Vasectomy International, and World Vasectomy Day) to promote high-quality vasectomy services in low-resource countries.

Dr. Joel L. Marmar has had a distinguished career practicing and teaching urology spanning nearly 40 years. A graduate of University of Pennsylvania School of Medicine, Dr. Marmar retired from Cooper University Hospital in 2013 after 41 years of service, including 26 years as Division Head. He was a Professor of Surgery and Urology at the Cooper Medical School of Rowan University. Dr. Marmar has been very involved in performing and training others in no-scalpel vasectomy techniques and in vasectomy reversal, both in the US and throughout the world.


Dr. Marmar is an author of AUA Vasectomy Guidelines published in 2012. He is the developer of the “In-Line Vasectomy (ILV)” technique – an improved method for performing a no-scalpel vasectomy. His patented devices for ILV are commercially available. A recognized leader in the field of male infertility for many years, Dr. Marmar has published over 60 scientific papers in peer review journals. In addition, he continues to review for several medical journals, and he was cited as a top “Reviewer” for the journal “Urology”, 2015-16. He is the recipient of many awards and a member of numerous urological societies.


Until recently, Dr. Marmar was the Director of Men’s Health Services for Planned Parenthood on Central and Southern New Jersey. Dr. Marmar has advised on the bipolar Signati vasectomy device virtually since its inception, and performed the rabbit study that demonstrated its effectiveness.


Not approved by the Food and Drug Admisistration (FDA).

These statements and the subject product have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The device is not currently being marketed, nor is it available for sale in any country.



Not approved by the Food and Drug Admisistration (FDA).

These statements and the subject product have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The device is not currently being marketed, nor is it available for sale in any country.